Home/NOVITÀ/Press Releases/TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Press ReleasesTIF News (IT)NOVITÀ TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Less than a minute 211020_ TIF Announcement_COVID-19 Vaccine Boosters TagsCOVID-19 Pandemic Vulnerable COVID-19 Vaccines AtRisk Thalassaemia Haemoglobin Disorders Vaccinations COVID-19 TIF News #news Sickle cell Healthcare Professionals Patients Less than a minute Facebook Twitter LinkedIn Share via Email Print
